Paper
Encapsulation of monomyristin into polymeric nanoparticles improved its in vitro antiproliferative activity against cervical cancer cells.
Published Apr 1, 2019 · Sirirat Boondireke, M. Léonard, A. Durand
Colloids and surfaces. B, Biointerfaces
Q1 SJR score
16
Citations
0
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
In Vitro StudyStudy Snapshot
Encapsulating monomyristin into polymeric nanoparticles improves its antiproliferative activity against cervical cancer cells, while being safe to normal cells.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Transferrin-Conjugated Nanocarriers as Active-Targeted Drug Delivery Platforms for Cancer Therapy.
Transferrin-conjugated nanocarriers show potential for active tumor-targeting drug delivery, reducing off-target effects and enhancing therapeutic benefits while minimizing side effects in cancer therapy.
2016·35citations·D. R. Nogueira-Librelotto et al.·Current pharmaceutical design
Current pharmaceutical design
Recent advances in interactions of designed nanoparticles and cells with respect to cellular uptake, intracellular fate, degradation and cytotoxicity
Recent advances in nanoparticle-cell interactions reveal factors affecting uptake, intracellular fate, degradation, and cytotoxicity, guiding optimization for biomedical applications.
2016·29citations·Jun Deng et al.·Nanotechnology
Nanotechnology
Doxorubicin-loaded biodegradable self-assembly zein nanoparticle and its anti-cancer effect: Preparation, in vitro evaluation, and cellular uptake.
DOX-loaded zein nanoparticles show high encapsulation efficiency and loading efficiency, with better cancer cell killing at low concentrations compared to free DOX.
2016·102citations·Fangyuan Dong et al.·Colloids and surfaces. B, Biointerfaces
Colloids and surfaces. B, Biointerfaces
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
GLOBOCAN 2012 estimates show that lung, breast, and colorectal cancers are the most common diagnosed and fatal cancers worldwide, with lung cancer being the most common cause of death.
2015·26289citations·J. Ferlay et al.·International Journal of Cancer
International Journal of Cancer
Endocytic mechanism of transferrin-conjugated nanoparticles and the effects of their size and ligand number on the efficiency of drug delivery.
Larger transferrin-conjugated nanoparticles can efficiently deliver drugs to cancer cells expressing many TfRs, potentially improving drug delivery efficiency.
2013·35citations·Takuma Tsuji et al.·Microscopy
Microscopy
Citations
Oral nano-formulations for endocrine therapy of endometrioid adenocarcinomas.
Oral nano-formulations can enhance the solubility and site specificity of drugs for endometrioid adenocarcinomas, improving their clinical use and preserving fertility in young patients.
2024·0citations·Minghua Cui et al.·Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Angelicin inhibits cell growth and promotes apoptosis in oral squamous cell carcinoma by negatively regulating DUSP6/cMYC signaling pathway.
Angelicin has antitumor effects on oral squamous cell carcinoma by negatively regulating the DUSP6/cMYC signaling pathway, offering a potential alternative treatment option with lower toxicity.
2023·0citations·Na Liu et al.·Experimental cell research
Experimental cell research
Metabolic syndromes responsible for cervical cancer and advancement of nanocarriers for efficient targeted drug delivery- A review
Metabolic syndromes contribute to cervical cancer, and nanocarriers enhance targeted drug delivery, increasing absorption rates and reducing side effects.
2022·10citations·Sumel Ashique et al.·Advances in Cancer Biology - Metastasis
Advances in Cancer Biology - Metastasis
Structural, electronic properties (different solvents), chemical reactivity, ELF, LOL, spectroscopic insights, molecular docking and in vitro anticancer activity studies on methyl (4-nitro-1-imidazolyl)acetate
M4NIA shows potential as an anticancer lead compound, with its molecular reactivity, electronic properties, and in vitro anticancer activity suggesting it could be a promising agent.
2022·24citations·S. Janani et al.·Journal of the Indian Chemical Society
Journal of the Indian Chemical Society
Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics
Nanomedicines show potential in overcoming cancer drug resistance, improving drug solubility, and reducing side effects while maintaining effectiveness in clinical settings.
2020·51citations·Anna Ulldemolins et al.·Cancer Drug Resistance
Cancer Drug Resistance
Novel nanotechnology approaches for diagnosis and therapy of breast, ovarian and cervical cancer in female: A review
Nanotechnology offers promising drug delivery systems for breast, cervical, and ovarian cancer, enabling precise targeting, maintaining bioactivity, and reducing cytotoxicity.
2020·24citations·A. Zafar et al.·Journal of Drug Delivery Science and Technology
Journal of Drug Delivery Science and Technology
Thermosensitive injectable hydrogel containing carboplatin loaded nanoparticles: A dual approach for sustained and localized delivery with improved safety and therapeutic efficacy
The developed in situ hydrogel with carboplatin-loaded nanoparticles provides a safe and efficient delivery system for sustained and localized carboplatin treatment, improving patient compliance.
2020·36citations·Shubham Thakur et al.·Journal of Drug Delivery Science and Technology
Journal of Drug Delivery Science and Technology
Recent Trends in Nanocarrier-Based Targeted Chemotherapy: Selective Delivery of Anticancer Drugs for Effective Lung, Colon, Cervical, and Breast Cancer Treatment
Nanoparticles enhance targeted chemotherapy by enhancing drug permeability and tumor retention, potentially improving treatment outcomes for lung, colon, cervical, and breast cancers.
2020·47citations·Ke-Tao Jin et al.·Journal of Nanomaterials
Journal of Nanomaterials